Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Protocol for open-label, randomised, controlled trial of intensive surveillance vs. standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer (SARONG trial).
Authors
Sheraz Markar
University of Oxford, Oxford, United Kingdom
Sheraz Markar , Alice Guazzelli , Amy Taylor , Laura Lloyd Jones , Vidoushee Jogarah , David Cromwell , Filipa Landeiro , Nick Maynard , Jesper Lagergren , Fergus Gleeson , Tim Underwood , Alan Moss , Tom David Lewis Crosby
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers
Track
Esophageal and Gastric Cancer,Small Bowel Cancer,Other GI Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
14417629
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr TPS416)
DOI
10.1200/JCO.2024.42.3_suppl.TPS416
Abstract #
TPS416
Poster Bd #
N1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Gastric microbiome signature to predict metachronous recurrence after endoscopic resection of gastric neoplasms.
First Author: Hokyoung Lee
Poster
2023 ASCO Annual Meeting
A prospective, open-label, randomized, controlled trial of radiofrequency ablation versus stereotactic body radiation therapy for recurrent small hepatocellular carcinoma.
First Author: Yaojun Zhang
Poster
2021 ASCO Annual Meeting
Risk factors for recurrence in each pattern after curative gastrectomy for pStage II/III gastric cancer: An exploratory analysis of a randomized controlled trial (JCOG1001).
First Author: Tetsuro Toriumi
Poster
2021 Gastrointestinal Cancers Symposium
Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-2N0-2 gastric cancer patients: Japan Clinical Oncology Group study JCOG1907 (MONA LISA study).
First Author: Rie Makuuchi